Clinical laboratories face a complex regulatory landscape, including multiple federal and state regulators. HPM has significant experience representing clinical laboratories on a variety of legal, regulatory, and compliance issues, including those with novel technology (e.g., methods, tests, next generation sequencing, various “omics”), algorithms, and biomarkers. We are committed to helping clinical laboratories bring their tests to patients and healthcare providers, and navigate a changing regulatory landscape.